CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionCurrent ratio is 10.81×, higher than 95% of its Medical Instruments & Supplies peers (median 2.21×)
- FinancialsAltman Z-Score 11.97: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.11%
Annual Rate
CNY 0.47Paid annual
Payout Ratio
18.5%Sustainable
Payback Period
92.5 yr
Last Ex-Dividend
May 28, 2026
The reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
5.64BCNY836.46M · vs all stocks (USD)
Trailing P/E
30.81xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.20BCNY178.44M · vs all stocks (USD)
Profit Margin
15.97%vs Medical Instruments & Supplies peers
Beta
0.4200xvs all stocks
52-Week Change
-38.06%vs all stocks
Market Capitalization
5.64BCNY836.46M · vs all stocks (USD)
Enterprise Value
3.43BCNY509.20M · vs all stocks (USD)
Trailing P/E
30.81xvs Medical Instruments & Supplies peers
Forward P/E
15.74xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
4.91xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.92xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.85xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
15.20xvs Medical Instruments & Supplies peers
Gross Margin
54.33%vs Medical Instruments & Supplies peers
Profit Margin
15.97%vs Medical Instruments & Supplies peers
Operating Margin
18.78%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
3.97%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
6.61%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.20BCNY178.44M · vs all stocks (USD)
Revenue per Share (TTM)
9.66CNYUpdated Aug 19, 2026Quarterly Revenue Growth
16.50%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
640.00MCNY94.91M · vs all stocks (USD)
EBITDA (TTM)
286.81MCNY42.53M · vs all stocks (USD)
Net Income (TTM)
192.15MCNY28.50M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-46.60%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
123.54MCNY18.32M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
32.16MCNY4.77M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.4714CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
1.11%vs all stocks
Payout Ratio
18.52%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
12.66MCNYFY2025 · Dec 31, 2025Revenue
1.16BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
545.71MCNYFY2025 · Dec 31, 2025Gross Profit
613.70MCNYFY2025 · Dec 31, 2025Operating Income
241.65MCNY35.84M · vs all stocks (USD)
Pre-tax Income
261.36MCNYFY2025 · Dec 31, 2025Income Tax Expense
30.10MCNYFY2025 · Dec 31, 2025Net Income
231.26MCNYFY2025 · Dec 31, 2025EBIT
266.33MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
309.57MCNYFY2025 · Dec 31, 2025Research & Development
139.12MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
156.81MCNYFY2025 · Dec 31, 2025Other Operating Expenses
12.21MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
14.89MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
4.97MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.81CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.81CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
124.38MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
124.38MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
231.26MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-5.60MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
74.00MCNYFY2025 · Dec 31, 2025Free Cash Flow
41.93MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.07BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
231.26MCNYFY2025 · Dec 31, 2025Other Non-cash Items
10.17MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-135.35MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-32.07MCNYFY2025 · Dec 31, 2025Capital Expenditures
-32.07MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.58BCNYFY2025 · Dec 31, 2025Sale of Investments
5.39BCNYFY2025 · Dec 31, 2025Other Investing Activity
36.93MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
819.22MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
447.31MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-706.47MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-41.94MCNYFY2025 · Dec 31, 2025Other Financing Charges
-39.28MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-340.38MCNYFY2025 · Dec 31, 2025Shares Outstanding
125.44MSharesUpdated Aug 19, 2026Float Shares
57.87MSharesUpdated Aug 19, 2026% Held by Insiders
53.32%vs all stocks
% Held by Institutions
17.60%vs all stocks
Total Cash (MRQ)
2.53BCNY374.96M · vs all stocks (USD)
Total Cash per Share (MRQ)
20.21CNYUpdated Aug 19, 2026Total Debt (MRQ)
49.32MCNY7.31M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0160xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
10.81xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
24.59CNYUpdated Aug 19, 2026Total Assets
3.38BCNY502.00M · vs all stocks (USD)
Total Current Assets
3.06BCNYFY2025 · Dec 31, 2025Total Liabilities
341.39MCNYFY2025 · Dec 31, 2025Total Non-current Assets
325.00MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
3.15MCNYFY2025 · Dec 31, 2025Total Current Liabilities
338.24MCNYFY2025 · Dec 31, 2025Cash
1.06BCNYFY2025 · Dec 31, 2025Cash Equivalents
5.75MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.07BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.52BCNYFY2025 · Dec 31, 2025Accounts Receivable
241.77MCNYFY2025 · Dec 31, 2025Inventory
115.79MCNYFY2025 · Dec 31, 2025Accounts Payable
138.67MCNYFY2025 · Dec 31, 2025Short-term Debt
81.18MCNYFY2025 · Dec 31, 2025Other Current Liabilities
24.97MCNYFY2025 · Dec 31, 2025Long-term Debt
2.83MCNYFY2025 · Dec 31, 2025Common Stock (Book)
89.60MCNYFY2025 · Dec 31, 2025Retained Earnings
1.18BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.04BCNY451.37M · vs all stocks (USD)
Treasury Stock
44.28MCNYFY2025 · Dec 31, 202552-Week Low
37.52CNYUpdated Aug 19, 202652-Week High
74.59CNYUpdated Aug 19, 202652-Week Change
-38.06%vs all stocks
Beta
0.4200xvs all stocks
50-Day MA
43.98CNYUpdated Aug 19, 2026200-Day MA
52.82CNYUpdated Aug 19, 2026Avg 10-Day Volume
2.44MSharesUpdated Aug 19, 2026Avg 30-Day Volume
3.80MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
1.53CNYUpdated Aug 19, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Debt Falling While Share Count Rises
Debt has fallen for four years while the share count rose over eight.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 10.81×, higher than 95% of its Medical Instruments & Supplies peers (median 2.21×)Significant
Current ratio: 10.81Industry median: 2.21Industry P95: 10.51Peers compared: 65.00
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.17Receivables vs revenue divergence: 6.71
Financial Health
Altman Z-Score 11.97: safe zoneNotable
Altman Z-Score: 11.97
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Nano Nuclear Energy Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Pourin Special Welding Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Suzhou Convert Semiconductor Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Macmic Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Jiangsu Huachang Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Quanex Building Products Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Baosteel Packaging Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sable Offshore Corp.
Tier 1ProductionThroughput-Bound ConversionRule
Zhejiang Zhongxin Fluoride Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Xunjiexing Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Shanghai Hajime Advanced Materials Co., Ltd.
3 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityLow-Leverage Liquidity ConfigurationDebt Falling While Share Count Rises
Hunan Heshun Petroleum Co., Ltd.
3 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityLow-Leverage Liquidity ConfigurationDebt Falling While Share Count Rises
Xuchang Ketop Testing Research Co., Ltd.
3 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityLow-Leverage Liquidity ConfigurationDebt Falling While Share Count Rises